A Long-Revered Resource in Academia
Published from 1965 until 2000 by the National Institute of Mental Health (NIMH), Psychopharmacology BULLETIN forged its path just as psychiatry itself was embarking on its golden era of treatment breakthroughs and recognition as a valid and independent field of medicine. Within months of MedWorks Media acquiring the rights to the title, the beloved Psychopharmacology BULLETIN was given a facelift, and a powerhouse Editor—Charles B. Nemeroff, MD, PhD, Chair of the Department at Emory University School of Medicine in Atlanta—was recruited.
The ABCs of Trends: A Mission of Influence
Indexed in a variety of databases including Index Medicus and PubMed since 1966, Bulletin’s influential name carries with it a certain responsibility to make sense of the trends in medicine for clinicians. With the primary catalyst for cutting-edge remission treatment in anxiety and depression—Michael E. Thase, MD—on board as the new Editor, the Bulletin will cover evidence based medicine as a section in every issue, along with original works on drug interactions and neuroscientific updates in translational work and imaging. Dr. Thase’s focus is on the future, on broadening the Bulletin’s scope, fostering an ability to engage readers actively, and expanding its already formidable sphere of influence in the field of neuropsychiatry.
